Valbiotis SA
PAR:ALVAL

Watchlist Manager
Valbiotis SA Logo
Valbiotis SA
PAR:ALVAL
Watchlist
Price: 0.7 EUR 4.17% Market Closed
Market Cap: 16.6m EUR

Wall Street
Price Targets

ALVAL Price Targets Summary
Valbiotis SA

Wall Street analysts forecast ALVAL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALVAL is 2.21 EUR with a low forecast of 2.12 EUR and a high forecast of 2.42 EUR.

Lowest
Price Target
2.12 EUR
203% Upside
Average
Price Target
2.21 EUR
216% Upside
Highest
Price Target
2.42 EUR
245% Upside
Valbiotis SA Competitors:
Price Targets
PRTA
Prothena Corporation PLC
117% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Upside
GNS
Genus PLC
15% Upside
CRSP
CRISPR Therapeutics AG
46% Upside
ABNX
Abionyx Pharma SA
213% Upside
ALT
Altimmune Inc
387% Upside
301207
Hualan Biological Bacterin Inc
3% Upside
FHTX
Foghorn Therapeutics Inc.
110% Upside

Revenue
Forecast

Revenue Estimate
Valbiotis SA

For the last 7 years the compound annual growth rate for Valbiotis SA's revenue is 79%. The projected CAGR for the next 3 years is 368%.

79%
Past Growth
368%
Estimated Growth
Estimates Accuracy
-51%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Valbiotis SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Valbiotis SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALVAL's stock price target?
Price Target
2.21 EUR

According to Wall Street analysts, the average 1-year price target for ALVAL is 2.21 EUR with a low forecast of 2.12 EUR and a high forecast of 2.42 EUR.

What is Valbiotis SA's Revenue forecast?
Projected CAGR
368%

For the last 7 years the compound annual growth rate for Valbiotis SA's revenue is 79%. The projected CAGR for the next 3 years is 368%.

Back to Top